SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to demonstrate how dronedarone (Multaq®) may aid in
the slowing of progression of left atrial and ventricular fibrosis in patients with atrial
fibrillation as assessed by late gadolinium enhanced magnetic resonance imaging.